These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 21723867

  • 1. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT, Nunes-de-Souza RL.
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [Abstract] [Full Text] [Related]

  • 2. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O, Spiacci A, Zangrossi H.
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [Abstract] [Full Text] [Related]

  • 3. Contrasting effects of nitric oxide and corticotropin- releasing factor within the dorsal periaqueductal gray on defensive behavior and nociception in mice.
    Miguel TT, Gomes KS, Nunes-de-Souza RL.
    Braz J Med Biol Res; 2012 Apr; 45(4):299-307. PubMed ID: 22450373
    [Abstract] [Full Text] [Related]

  • 4. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT, Nunes-de-Souza RL.
    Brain Res; 2008 Nov 13; 1240():39-46. PubMed ID: 18793618
    [Abstract] [Full Text] [Related]

  • 5. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J, Nunes-de-Souza RL.
    Brain Res; 2005 Jun 14; 1047(1):97-104. PubMed ID: 15893297
    [Abstract] [Full Text] [Related]

  • 6. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA.
    Psychopharmacology (Berl); 2003 Nov 14; 170(2):178-87. PubMed ID: 12845406
    [Abstract] [Full Text] [Related]

  • 7. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D, Nunes-de-Souza RL, Canto-de-Souza A.
    Behav Brain Res; 2012 Nov 01; 235(1):42-7. PubMed ID: 22800924
    [Abstract] [Full Text] [Related]

  • 8. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis.
    Miguel TT, Nunes-de-Souza RL.
    Brain Res; 2006 Mar 03; 1076(1):42-8. PubMed ID: 16476419
    [Abstract] [Full Text] [Related]

  • 9. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.
    Martins AP, Marras RA, Guimarães FS.
    Depress Anxiety; 2000 Mar 03; 12(2):99-101. PubMed ID: 11091933
    [Abstract] [Full Text] [Related]

  • 10. Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain.
    Nijsen M, Ongenae N, Meulemans A, Coulie B.
    Neurogastroenterol Motil; 2005 Jun 03; 17(3):423-32. PubMed ID: 15916630
    [Abstract] [Full Text] [Related]

  • 11. CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors.
    Litvin Y, Pentkowski NS, Blanchard DC, Blanchard RJ.
    Horm Behav; 2007 Aug 03; 52(2):244-51. PubMed ID: 17540371
    [Abstract] [Full Text] [Related]

  • 12. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
    Miguel TT, Gomes KS, Nunes-de-Souza RL.
    Horm Behav; 2014 Jul 03; 66(2):247-56. PubMed ID: 24848364
    [Abstract] [Full Text] [Related]

  • 13. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.
    Sahuque LL, Kullberg EF, Mcgeehan AJ, Kinder JR, Hicks MP, Blanton MG, Janak PH, Olive MF.
    Psychopharmacology (Berl); 2006 May 03; 186(1):122-32. PubMed ID: 16568282
    [Abstract] [Full Text] [Related]

  • 14. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
    Cipriano AC, Gomes KS, Nunes-de-Souza RL.
    Horm Behav; 2016 May 03; 81():59-67. PubMed ID: 27060334
    [Abstract] [Full Text] [Related]

  • 15. Anxiolytic-like effects produced by bilateral lesion of the periaqueductal gray in mice: Influence of concurrent nociceptive stimulation.
    Mendes-Gomes J, Nunes-de-Souza RL.
    Behav Brain Res; 2009 Nov 05; 203(2):180-7. PubMed ID: 19410607
    [Abstract] [Full Text] [Related]

  • 16. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
    Mascarenhas DC, Gomes KS, Nunes-de-Souza RL.
    Behav Brain Res; 2013 Aug 01; 250():308-15. PubMed ID: 23707246
    [Abstract] [Full Text] [Related]

  • 17. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
    Borelli KG, Brandão ML.
    Horm Behav; 2008 Jan 01; 53(1):40-50. PubMed ID: 17920596
    [Abstract] [Full Text] [Related]

  • 18. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
    Liu S, Gao X, Gao N, Wang X, Fang X, Hu HZ, Wang GD, Xia Y, Wood JD.
    J Comp Neurol; 2005 Jan 17; 481(3):284-98. PubMed ID: 15593376
    [Abstract] [Full Text] [Related]

  • 19. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF.
    J Pharmacol Exp Ther; 2004 Sep 17; 310(3):1027-34. PubMed ID: 15115804
    [Abstract] [Full Text] [Related]

  • 20. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
    Mascarenhas DC, Gomes KS, Nunes-de-Souza RL.
    Behav Brain Res; 2015 Oct 01; 292():547-54. PubMed ID: 26183651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.